drugset / Trial / NCT07139431
A Study of [89Zr]-Oxine-NCR100 Injection for the Cellular Distribution
NaSequentialOpen-labelTreatment
Summary
This clinical study is to evaluate the biodistribution of \[89Zr\]-Oxine-NCR100 injection in subjects with knee osteoarthritis after local injection and the kinetic behavior characteristics of zirconium-labeled cells at the injection site and various organs or tissues. It is a single-dose, open-label study in adult KOA subjects.
Timeline
- Start
- 2025-08-29
- Primary completion
- 2026-03-06
- Completion
- 2028-04-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NCR100 | Cell therapy | — | — |
Indications
No indication recorded.